News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,561 Results
Type
Article (87275)
Company Profile (738)
Press Release (770520)
Multimedia
Podcasts (165)
Webinars (26)
Section
Business (232994)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91214)
Employer Resources (201)
FDA (18251)
Job Trends (17389)
News (397238)
Policy (39906)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (121)
Alliances (56979)
ALS (138)
Alzheimer's disease (1650)
Antibody-drug conjugate (ADC) (207)
Approvals (18255)
Artificial intelligence (461)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (152)
Biotechnology (483)
Bladder cancer (119)
Brain cancer (47)
Breast cancer (444)
Cancer (3584)
Cardiovascular disease (313)
Career advice (3551)
Career pathing (36)
CAR-T (232)
CDC (51)
Cell therapy (635)
Cervical cancer (30)
Clinical research (75004)
Collaboration (1299)
Company closure (4)
Compensation (871)
Complete response letters (51)
COVID-19 (2943)
CRISPR (79)
C-suite (520)
Cystic fibrosis (130)
Data (3876)
Decentralized trials (2)
Denatured (59)
Depression (103)
Diabetes (432)
Diagnostics (7054)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (219)
Drug pricing (170)
Drug shortages (36)
Duchenne muscular dystrophy (185)
Earnings (98648)
Editorial (53)
Employer branding (25)
Employer resources (170)
Events (132477)
Executive appointments (961)
FDA (20526)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1151)
Gene editing (166)
Generative AI (45)
Gene therapy (503)
GLP-1 (1003)
Government (5354)
Grass and pollen (7)
Guidances (334)
Healthcare (20936)
HIV (48)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (227)
Immuno-oncology (19)
Indications (49)
Infectious disease (3164)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (168)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (71)
Layoffs (628)
Leadership (31)
Legal (10144)
Liver cancer (91)
Longevity (12)
Lung cancer (516)
Lymphoma (252)
Machine learning (24)
Management (65)
Manufacturing (581)
MASH (121)
Medical device (14835)
Medtech (14853)
Mergers & acquisitions (22682)
Metabolic disorders (1097)
Multiple sclerosis (123)
NASH (23)
Neurodegenerative disease (190)
Neuropsychiatric disorders (52)
Neuroscience (2575)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (546)
Opinion (304)
Ovarian cancer (117)
Pain (156)
Pancreatic cancer (150)
Parkinson's disease (218)
Partnered (28)
Patents (388)
Patient recruitment (274)
Peanut (57)
People (66093)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23122)
Phase II (32575)
Phase III (24511)
Pipeline (2507)
Policy (282)
Postmarket research (3554)
Preclinical (10442)
Press Release (72)
Prostate cancer (177)
Psychedelics (50)
Radiopharmaceuticals (281)
Rare diseases (614)
Real estate (7412)
Recruiting (77)
Regulatory (27756)
Reports (64)
Research institute (2679)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (65)
Schizophrenia (123)
Series A (191)
Series B (144)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (84)
The Weekly (104)
Vaccines (1014)
Venture capital (63)
Weight loss (380)
Women's health (56)
Worklife (21)
Date
Today (96)
Last 7 days (608)
Last 30 days (2458)
Last 365 days (33884)
2025 (24100)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50836)
Australia (8926)
California (8987)
Canada (2731)
China (855)
Colorado (379)
Connecticut (401)
Delaware (244)
Europe (116742)
Florida (1323)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (788)
India (47)
Indiana (436)
Iowa (19)
Japan (276)
Kansas (123)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1225)
Massachusetts (6759)
Michigan (298)
Minnesota (546)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2480)
New Mexico (32)
New York (2449)
North Carolina (1370)
North Dakota (10)
Northern California (4004)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1870)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3422)
Tennessee (142)
Texas (1407)
United States (33314)
Utah (268)
Virginia (239)
Washington D.C. (82)
Washington State (773)
West Virginia (4)
Wisconsin (92)
There are 858,561 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
September 23, 2025
·
6 min read
Press Releases
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
September 23, 2025
·
4 min read
Press Releases
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
September 23, 2025
·
4 min read
Press Releases
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
September 23, 2025
·
6 min read
Press Releases
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
September 23, 2025
·
6 min read
Press Releases
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences’ Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
September 23, 2025
·
4 min read
Press Releases
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
September 23, 2025
·
4 min read
Press Releases
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
September 23, 2025
·
4 min read
Press Releases
Coya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis
September 23, 2025
·
8 min read
Press Releases
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
September 23, 2025
·
4 min read
1 of 85,857
Next